Jeffrey S. Johnston

883 total citations
23 papers, 648 citations indexed

About

Jeffrey S. Johnston is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jeffrey S. Johnston has authored 23 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Jeffrey S. Johnston's work include Lymphoma Diagnosis and Treatment (5 papers), Telomeres, Telomerase, and Senescence (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Jeffrey S. Johnston is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Telomeres, Telomerase, and Senescence (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Jeffrey S. Johnston collaborates with scholars based in United States, Canada and Japan. Jeffrey S. Johnston's co-authors include Yuebo Gan, Jessie L.‐S. Au, M. Guillaume Wientjes, Tomoko Oh‐hara, Wan Yong Feng, Takashi Tsuruo, Fujiko Oh-hashi, Kenneth Chun‐Ho Chan, Imad Naasani and Yiqun Mo and has published in prestigious journals such as Blood, Cancer and FEBS Letters.

In The Last Decade

Jeffrey S. Johnston

23 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey S. Johnston United States 14 302 150 149 93 70 23 648
Narazah Mohd Yusoff Malaysia 17 448 1.5× 244 1.6× 45 0.3× 86 0.9× 107 1.5× 79 1.0k
Yuki Nakajima Japan 18 297 1.0× 197 1.3× 129 0.9× 29 0.3× 73 1.0× 79 816
T.T. Kwok Hong Kong 18 541 1.8× 227 1.5× 125 0.8× 62 0.7× 23 0.3× 24 974
Claudia Gemetzi Greece 8 201 0.7× 130 0.9× 110 0.7× 59 0.6× 74 1.1× 11 736
Rit Vatsyayan United States 22 634 2.1× 178 1.2× 47 0.3× 73 0.8× 28 0.4× 33 1.1k
Senthilnathan Palaniyandi United States 16 272 0.9× 129 0.9× 51 0.3× 43 0.5× 54 0.8× 32 707
Bilal Rah India 20 653 2.2× 238 1.6× 72 0.5× 82 0.9× 23 0.3× 47 1.2k
Łukasz Sędek Poland 16 306 1.0× 113 0.8× 77 0.5× 42 0.5× 52 0.7× 59 771
Youqiu Xue China 13 331 1.1× 173 1.2× 60 0.4× 23 0.2× 61 0.9× 18 734
Luigi Candussio Italy 15 231 0.8× 255 1.7× 31 0.2× 40 0.4× 33 0.5× 42 664

Countries citing papers authored by Jeffrey S. Johnston

Since Specialization
Citations

This map shows the geographic impact of Jeffrey S. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Johnston more than expected).

Fields of papers citing papers by Jeffrey S. Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Johnston. The network helps show where Jeffrey S. Johnston may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Johnston. A scholar is included among the top collaborators of Jeffrey S. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Johnston. Jeffrey S. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poi, Ming, Craig C. Hofmeister, Jeffrey S. Johnston, et al.. (2013). Standard Pentostatin Dose Reductions in Renal Insufficiency Are Not Adequate: Selected Patients with Steroid-Refractory Acute Graft-Versus-Host Disease. Clinical Pharmacokinetics. 52(8). 705–712. 3 indexed citations
2.
Walker, Alison R., Rebecca B. Klisovic, Jeffrey S. Johnston, et al.. (2012). Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma. 54(9). 1996–2002. 24 indexed citations
3.
Baiocchi, Robert A., Lapo Alinari, Mark Lustberg, et al.. (2010). Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma. Cancer. 117(11). 2442–2451. 38 indexed citations
4.
Knoell, Daren L., Jeffrey S. Johnston, Shengying Bao, & Katherine A. Kelley. (2009). A Genotyping Exercise for Pharmacogenetics in Pharmacy Practice. American Journal of Pharmaceutical Education. 73(3). 43–43. 34 indexed citations
5.
Alinari, Lapo, Timothy P. Ryan, Jeffrey S. Johnston, et al.. (2009). Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma. mAbs. 1(1). 31–40. 28 indexed citations
6.
Johnston, Jeffrey S., et al.. (2009). Anesthesia for brain tumor resection using intraoperative magnetic resonance imaging (iMRI) with the Polestar N-20 system: experience and challenges. Journal of Clinical Anesthesia. 21(5). 371–376. 16 indexed citations
7.
Knoell, Daren L., Jeffrey S. Johnston, Shengying Bao, & Katherine A. Kelley. (2009). A Genotyping Exercise for Pharmacogenetics in Pharmacy Practice. American Journal of Pharmaceutical Education. 73(3). 43–43. 4 indexed citations
8.
Blum, Kristie A., Robert A. Baiocchi, Lapo Alinari, et al.. (2008). A Phase II Trial of Induction Plus Maintenance Rituximab and Bortezomib in Patients with Relapsed/Refractory Mantle Cell (MCL) and Follicular (FL) Non-Hodgkin’s Lymphoma. Blood. 112(11). 3053–3053. 4 indexed citations
9.
10.
11.
Johnston, Jeffrey S., et al.. (2008). Gastric Duplication Cysts Expressing Carcinoembryonic Antigen Mimicking Cystic Pancreatic Neoplasms in Two Adults. The American Surgeon. 74(1). 91–94. 19 indexed citations
12.
Blum, Kristie A., Margaret S. Lucas, Jeffrey S. Johnston, et al.. (2006). Excessive Neurotoxicity in a Phase II Trial of Combined Bortezomib and Rituximab in Patients with Relapsed/Refractory Mantle Cell (MCL) and Follicular (FL) Non-Hodgkin’s Lymphoma.. Blood. 108(11). 2768–2768. 1 indexed citations
13.
Ekins, Sean, Jeffrey S. Johnston, Praveen M. Bahadduri, et al.. (2005). In Vitro and Pharmacophore-Based Discovery of Novel hPEPT1 Inhibitors. Pharmaceutical Research. 22(4). 512–517. 50 indexed citations
14.
Gao, Wenqing, Jeffrey S. Johnston, Duane D. Miller, & James T. Dalton. (2005). INTERSPECIES DIFFERENCES IN PHARMACOKINETICS AND METABOLISM OF S-3-(4-ACETYLAMINO-PHENOXY)-2-HYDROXY-2-METHYL-N-(4-NITRO-3-TRIFLUOROMETHYLPHENYL)-PROPIONAMIDE: THE ROLE OF N-ACETYLTRANSFERASE. Drug Metabolism and Disposition. 34(2). 254–260. 15 indexed citations
15.
Lin, T. S., Jeffrey S. Johnston, James T. Dalton, et al.. (2005). Combination Bortezomib (PS341, Velcade) and Rituximab Treatment Affects Multiple Survival and Death Pathways To Promote Apoptosis in Mantle Cell Lymphoma.. Blood. 106(11). 2407–2407. 6 indexed citations
16.
Naasani, Imad, Fujiko Oh-hashi, Tomoko Oh‐hara, et al.. (2003). Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.. PubMed. 63(4). 824–30. 173 indexed citations
17.
Johnston, Jeffrey S., Andrew D. Johnson, Yuebo Gan, M. Guillaume Wientjes, & Jessie L.‐S. Au. (2003). Synergy Between 3′Azido-3′deoxythymidine and Paclitaxel in Human Pharynx FaDu Cells. Pharmaceutical Research. 20(7). 957–961. 27 indexed citations
18.
Mo, Yiqun, Yuebo Gan, Jeffrey S. Johnston, et al.. (2003). Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.. PubMed. 63(3). 579–85. 78 indexed citations
19.
Gan, Yuebo, Yiqun Mo, Jeffrey S. Johnston, et al.. (2002). Telomere maintenance in telomerase‐positive human ovarian SKOV‐3 cells cannot be retarded by complete inhibition of telomerase. FEBS Letters. 527(1-3). 10–14. 18 indexed citations
20.
Au, Jessie L.‐S., Dong Li, Yuebo Gan, et al.. (1998). Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.. PubMed. 58(10). 2141–8. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narazah Mohd Yusoff Breakdown of academic impact, for papers by Yuki Nakajima Breakdown of academic impact, for papers by T.T. Kwok Breakdown of academic impact, for papers by Claudia Gemetzi Breakdown of academic impact, for papers by Rit Vatsyayan Breakdown of academic impact, for papers by Senthilnathan Palaniyandi Breakdown of academic impact, for papers by Bilal Rah Breakdown of academic impact, for papers by Łukasz Sędek Breakdown of academic impact, for papers by Youqiu Xue Breakdown of academic impact, for papers by Luigi Candussio
Rankless by CCL
2026